Clinical Education

Advancing Medical Cannabis Through Education

The International Society of Cannabis Pharmacists (ISCPh) is committed to advancing the safe, evidence-informed use of medical cannabis through high-quality professional education. As cannabinoid science, regulations, and clinical practice continue to evolve, healthcare professionals need education that is practical, unbiased, and grounded in the best available evidence.

Our mission is to promote excellence in medical cannabis care by empowering pharmacists and other healthcare professionals with the knowledge and clinical skills needed to improve patient outcomes. We believe pharmacists play a vital role in medication management, patient safety, and interdisciplinary collaboration, and our educational programs are designed to support that role.

ISCPh educational activities are developed by experienced clinicians, researchers, and educators with expertise in cannabinoid pharmacology, therapeutics, patient care, and regulatory science. Our medical cannabis education programs emphasize scientific integrity, critical appraisal of the literature, and practical application to real-world clinical practice.

Whether you are new to medical cannabis or seeking advanced clinical knowledge, ISCPh provides educational opportunities that support lifelong learning and professional development. Through certificate programs, continuing education, clinical resources, and future specialty training, we strive to establish a global standard for pharmacist education in medical cannabis.

Our Educational Principles

Evidence-Based

Every ISCPh educational program is developed using the best available scientific evidence. We emphasize critical appraisal of the literature, transparent discussion of the strength and limitations of current research, and application of evidence to clinical practice.

Patient-Centered

Our medical cannabis education is designed with one goal in mind: improving patient care. We promote individualized, compassionate, and evidence-informed approaches that prioritize medication safety, therapeutic outcomes, and quality of life.

Pharmacist-Led

Pharmacists are medication experts with a unique role in optimizing cannabinoid therapy. Our educational programs highlight the pharmacist’s contributions to medication management, dosing, product selection, drug interaction assessment, monitoring, and interprofessional collaboration.

Independent and Scientifically Rigorous

ISCPh is committed to delivering education that is objective, balanced, and free from commercial influence. Our content is developed through scientific review and reflects current clinical evidence rather than product promotion. Our medical cannabis education is grounded in science, guided by evidence, and focused on improving patient care.

Practical and Clinically Relevant

Education should translate directly into better patient care. Our programs focus on real-world clinical application, equipping healthcare professionals with practical tools, clinical decision-making strategies, and confidence to incorporate medical cannabis into patient care safely and effectively.

Lifelong Learning

Medical cannabis is a rapidly evolving field. ISCPh is committed to supporting healthcare professionals throughout their careers by providing educational opportunities that evolve alongside emerging research, clinical practice, and regulatory developments.

Global Perspective

Medical cannabis practice varies across healthcare systems and jurisdictions. Our educational programs encourage a broad understanding of international regulatory frameworks, evolving standards of care, and global best practices to support healthcare professionals wherever they practice.

We invite you to explore our educational programs below and join us in advancing safe, effective, and evidence-based patient care.

CliniCan Foundations

Cannabis Pharmacy 2023 & Me

Clinical Cannabinoid Pharmacy Conference 2020

Access Restriction

Welcome to the International Society of Cannabis Pharmacists

This portal contains educational and professional data regarding medical cannabis pharmacology. Access is restricted to healthcare experts and individuals aged 18 or older.

Access Denied

You do not meet the age criteria.
Redirecting to a secure resource...